Eric I. Richman's Insider Trades & SAST Disclosures
Eric I. Richman's most recent trade in Gain Therapeutics Inc was a trade of 12,000 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on July 1, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Eric I. Richman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gain Therapeutics Inc | Eric I. Richman | Director | Purchase of securities on an exchange or from another person at price $ 1.21 per share. | 01 Jul 2024 | 12,000 | 289,629 | - | 1.2 | 14,520 | Common Stock |
| Gain Therapeutics Inc | Eric I. Richman | Director | Purchase of securities on an exchange or from another person at price $ 1.23 per share. | 01 Jul 2024 | 5,000 | 277,629 | - | 1.2 | 6,150 | Common Stock |
| Gain Therapeutics Inc | Eric I. Richman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Gain Therapeutics Inc | Eric I. Richman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 329,400 | 329,400 | - | - | Employee Stock Option (right to buy) | |
| Gain Therapeutics Inc | Eric I. Richman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2022 | 54,900 | 54,900 | - | - | Restricted Stock Units | |
| NeuBase Therapeutics Inc | Eric I. Richman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2022 | 37,600 | 37,600 | - | - | Stock option (right to buy) | |
| Gain Therapeutics Inc | Eric I. Richman | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.58 per share. | 25 May 2022 | 2,482 | 217,729 | - | 2.6 | 6,404 | Common stock |
| Gain Therapeutics Inc | Eric I. Richman | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.83 per share. | 19 May 2022 | 9,256 | 215,247 | - | 2.8 | 26,194 | Common Stock |
| Gain Therapeutics Inc | Eric I. Richman | Director, CHIEF EXECUTIVE OFFICER | Purchase of securities on an exchange or from another person at price $ 2.71 per share. | 19 May 2022 | 4,000 | 205,991 | - | 2.7 | 10,840 | Common stock |
| NeuBase Therapeutics Inc | Eric I. Richman | Director | Purchase of securities on an exchange or from another person at price $ 1.58 per share. | 01 Mar 2022 | 1,580 | 42,660 (0%) | 0% | 1.6 | 2,496 | Common stock |
| NeuBase Therapeutics Inc | Eric I. Richman | Director | Purchase of securities on an exchange or from another person at price $ 1.72 per share. | 01 Mar 2022 | 1,300 | 43,960 (0%) | 0% | 1.7 | 2,236 | Common stock |
| NeuBase Therapeutics Inc | Eric I. Richman | Director | Purchase of securities on an exchange or from another person at price $ 1.62 per share. | 01 Mar 2022 | 1,000 | 44,960 (0%) | 0% | 1.6 | 1,620 | Common stock |
| NeuBase Therapeutics Inc | Eric I. Richman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2021 | 38,135 | 38,135 | - | - | Stock option (right to buy) | |
| Gain Therapeutics Inc | Eric I. Richman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.87 per share. | 16 Aug 2021 | 4,922 | 216,820 | - | 7.9 | 38,716 | Common Stock |
| NeuBase Therapeutics Inc | Eric I. Richman | Director | Purchase of securities on an exchange or from another person at price $ 5.00 per share. | 26 Apr 2021 | 5,000 | 41,080 (0%) | 0% | 5 | 25,000 | Common stock |
| NeuBase Therapeutics Inc | Eric I. Richman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2020 | 14,634 | 14,634 | - | - | Stock option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges